SecBot SecBot

EHSI

Elite Health Systems Inc.
OTC· Services-Specialty Outpatient Facilities, NEC· Inc. DE· CIK 0001089815 Healthcare & Medical Devices
$0.8300 +0.00 (+0.00%)
Oct 27 4:00 PM ET · prev $0.8300
1 year
−41.1%
from $1.41 · Oct 27
30 days
−2.4%
from $0.8500
52-week range
$0.6300–1.50
−45% from high · low Oct 1
Avg volume 20D
2.2K
Oct 2 spike 12.2K
Short interest
🔒 Subscribers only
Insider net
+$54.4K
1 buyer · 0 sellers · 12 mo
Filing reports
2
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest MIXED Elite Health Systems secured $525,000 in bridge financing from its CEO and chair via an unsecured…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $54.4K at an average $0.9755. No open-market sales. Price is 15% below their cost.

  • TrendDOWNTREND

    0% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 31, 2026 Insider
jeereddi Prasad Anjaneya was granted 68,421 shares
CEO
Aug 5, 2026 SEC
Elite Health Systems secured $525,000 in bridge financing from its CEO and chair via an unsecured subordinated note…
8-K — Impact 5/10
Jul 31, 2026 Insider
jeereddi Prasad Anjaneya was granted 110,526 shares
CEO
Jul 10, 2026 SEC
Elite Health Systems announced a formal strategic review authorized by its Board, including potential sale of assets…
8-K — Impact 6/10
Jul 2, 2026 Insider
jeereddi Prasad Anjaneya bought 42,105 shares
CEO @ $0.9500 ($40.0K)
May 22, 2026 Event
Methotrexate Sodium
WARNING: EMBRYO-FETAL TOXICITY, HYPERSENSITIVITY REACTIONS , SEVERE ADVERSE REACTIONS, and RISK OF M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
May 22, 2026
FDA
Methotrexate Sodium
WARNING: EMBRYO-FETAL TOXICITY, HYPERSENSITIVITY REACTIONS , SEVERE ADVERSE REACTIONS, and RISK OF MEDICATION ERRORS Methotrexate Tablets can cause em

Insider ledger

Form 4
$54.4K
bought · 1 insider
$0
sold · 0 insiders
−14.9%
vs their $0.9755 cost
DateInsiderTypeValue
Aug 31, 2026
jeereddi Prasad Anjaneya
CEO
AWARD68,421 sh
Jul 31, 2026
jeereddi Prasad Anjaneya
CEO
AWARD110,526 sh
Jul 2, 2026
jeereddi Prasad Anjaneya
CEO
BUY$40.0K
Jun 1, 2026
jeereddi Prasad Anjaneya
CEO
BUY$6.3K
May 15, 2026
jeereddi Prasad Anjaneya
CEO
BUY$6.3K
Apr 29, 2026
jeereddi Prasad Anjaneya
CEO
BUY$1.8K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 mixed
All EHSI filing & press-release reports (2)